Group C and group G streptococcus: guidance, data and analysis
The characteristics, diagnosis, management, and epidemiology of group C streptococci and group G streptococci.
Group C and group G streptococci include several species of bacteria, with the main human pathogen being Streptococcus dysgalactiae ssp. equisimilis. These bacteria usually cause throat, skin and soft tissue infections.
Group C and group G streptococci can also cause invasive infections like:
- bacteraemia
- endocarditis (inflammation of the lining of the heart)
- bone and joint infections
Toxic shock can follow both localised and invasive infections.
Group C and G streptococcal infections are spread by person to person contact, such as sneezing, coughing, or touching an open wound.
Group C and G streptococcal infections may be treated with antibiotics.
Epidemiology
PHE publishes reports on streptococcal infection rates in Health Protection Report (HPR).
Diagnosis and treatment
In the absence of specific Group C and G streptococcal guidance see guidance about group A streptococcal infections treatment.
Last updated 14 July 2021 + show all updates
-
Updated link under Diagnosis to AMRHAI, which now provides diagnostic services.
-
First published.